CATalyst Chat explores the future of translational science and personalized therapies

The final CATalyst Chat of the spring semester brought together alumni, industry leaders and community members for a conversation on translational science and the future of personalized medicine.

Held at the U of A Scottsdale Center, the presentation featured Dr. Ryan Sprissler, Associate Research Professor and Associate Director of the Center for Advanced Molecular and Immunological Therapies (CAMI), located on the University of Arizona’s Phoenix Bioscience Core campus.

Sprissler shared how advances in molecular and immunological therapies are reshaping the future of disease treatment, particularly through personalized immunotherapies tailored to individual genetic profiles. He also highlighted the changing landscape of biomedical innovation, where smaller biotechnology companies and academic research centers are playing an increasingly important role in moving discoveries from the laboratory into early-stage therapies.

At the center of this work is CAMI, which was created to accelerate the translation of university research into therapies with real-world impact. Through its entrepreneurial model, CAMI is helping bridge the gap between academic discovery and commercialization, advancing new treatment possibilities for patients in Arizona and beyond.

Attendees gained insight into the complexity of the human genome and the emerging role genetics may play in future therapies and disease prevention.

The event concluded another successful semester of Scottsdale Center CATalyst Chats, which continue to convene thought leaders, researchers and the broader community around the ideas and innovations shaping Arizona’s future.